SCHEMBL2762294

SCHEMBL2762294

COCC(=O)N1CCC(Oc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OC)CC1.COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCN(C(=O)N2CCOCC2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 17/20 0.67
▸ ERBB2 P04626 5/20 0.67
▸ KDR P35968 2/20 0.66
▸ EPHB4 P54760 2/20 0.66
▸ EPHA2 P29317 1/20 0.66
▸ BRAF P15056 2/20 0.59
▸ CIT O14578 1/20 0.59
▸ GAK O14976 1/20 0.59
▸ EPHB6 O15197 1/20 0.59
▸ ABCC4 O15439 1/20 0.59
▸ DAPK3 O43293 1/20 0.59
▸ RIPK2 O43353 1/20 0.59
▸ NR1I2 O75469 1/20 0.59
▸ RPS6KA4 O75676 1/20 0.59
▸ STK17B O94768 1/20 0.59
▸ STK10 O94804 1/20 0.59
▸ PRKD3 O94806 1/20 0.59
▸ ABCB11 O95342 1/20 0.59
▸ MAP4K4 O95819 1/20 0.59
▸ CHEK2 O96017 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185479 0.94 EGFR (0.74) EGFRERBB2KDREPHB4EPHA2
SCHEMBL29623589 0.94 EGFR (0.74) EGFRERBB2KDREPHB4EPHA2
SCHEMBL118271 0.94 EGFR (0.75) EGFRERBB2KDREPHB4EPHA2
SCHEMBL29623483 0.94 EGFR (0.75) EGFRERBB2KDREPHB4EPHA2
SCHEMBL1446518 0.92 EGFR (0.70) EGFRERBB2KDREPHB4EPHA2
SCHEMBL10285951 0.91 EGFR (0.71) EGFRERBB2KDREPHB4EPHA2
SCHEMBL29623541 0.90 EGFR (0.66) EGFRERBB2KDREPHB4BRAF
SCHEMBL175261 0.90 EGFR (0.66) EGFRERBB2KDREPHB4BRAF
SCHEMBL28572972 0.90 EGFR (0.66) EGFRERBB2KDREPHB4EPHA2
SCHEMBL1446536 0.90 ERBB2 (0.76) EGFRERBB2KDREPHB4EPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379525-B1 CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD BOEHRINGER INGELHEIM INT (DE) 2015-07-29 — — EP disclosed
EP-2393492-A1 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS Boehringer Ingelheim International GmbH (DE) 2011-12-14 — — EP disclosed
WO-2010089391-A1 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-08-12 — — WO disclosed
Send feedback